On August 11 to 12, 2022, a team of experts from Center for Drug Inspection of Fujian Provincial Medical Products Administration conducted an inspection and acceptance at our company. The expert team attentively listened to the report from the Supply Chain Center staff, posed questions regarding the quality management standards of the company in various aspects such as drug procurement, storage, preservation, sales, returns, transportation, and conducted an evaluation of the proper usage of GSP software.

On August 30th, 2022, Fujian Provincial Medical Products Administration officially issued the GSP Certificate to Sino Universal Pharma. With this, the GSP certification work, which our company attached great importance to, has come to a conclusion. Quality management is the lifeline of the enterprise. Although the certification work has been completed, the Supply Chain Center will continue to uphold the quality policy of "Quality is more important than Mount Tai, and service builds the brand." We will continue to strictly implement various quality management tasks in accordance with the requirements of the national drug regulatory authorities.

Once again, congratulations to our company for successfully passing the GSP certification! We would like to express our gratitude to government departments at all levels for their care and support for the development of SUP, to the expert group for their guidance, to our global partners for their support, and to all colleagues in various departments of the company who have worked hard for the construction of the supply chain. All SUPers will continue to uphold the mission of "Import High-quality Medicines Globally to Serve Healthy China", and open a new chapter in the global, digital, and information-driven development of the Supply Chain Center.